1. Gooptu B., Ekeowa U.I., Lomas D.A. Source Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights. Eur. Respir. J. 2009; 34 (2): 475–488.

2. Mostafavi S., Lieberman J. Intermediate alpha1-antitrypsin deficiency with apical lung bullae and spontaneous pneumothorax. Presence of a Z variant in an american black. Chest 1991; 99 (6): 1545–1546.

3. De Paepe A., Devereux R.B., Deitz H.C. et al. Revised diagnostic criteria for the Marfan syndrome. Am. J. Med. Genet. 1996; 62: 417–426.

4. Кадурина Т.И., Горбунова В.Н. Дисплазия соединительной ткани. Руководство для врачей. СПб.: Элби-СПб; 2009.

5. Wallace A.M., Sandford A.J., English J.C. et al. Matrix metalloproteinase expression by human alveolar macrophages in relation to emphysema. COPD 2008; 5 (1): 13–23.

6. Abolnik I. Z., Lossos I. S., Zlotogora J., Brauer R. On the inheritance of primary spontaneous pneumothorax. Am. J. Med. Genet. 1991; 40: 155–158.

7. Gunji Y., Akiyoshi T., Sato T. et al. Mutations of the Birt-Hogg-Dube gene in patients with multiple lung cysts and recurrent pneumothorax. J. Med. Genet. 2007; 44: 588–593.

8. Painter J. N., Tapanainen H., Somer M. et al. A 4-bp deletion in the Birt-Hogg-Dube gene (FLCN) causes dominantly inherited spontaneous pneumothorax. Am. J. Hum. Genet. 2005; 76: 522–527.

9. Lin Y.C., Chiu W.K., Chang H. et al. Spontaneous pneumothorax in flight as first manifestation of alpha-1 antitrypsin deficiency. Aviat. Space Environ. Med. 2008; 79 (7): 704–706.

10. Bense L., Lewander R., Eklund G. et al. Nonsmoking, nonalpha1-antitrypsin deficiency-induced emphysema in nonsmokers with healed spontaneous pneumothorax, identified by computed tomography of the lungs. Chest 1993; 103 (2): 433–438.

11. Высоцкий А.Г. Состояние антипротеазной системы крови у больных с буллезной эмфиземой легких и спонтанным пневмотораксом. Питання експер. клін. мед. 2004; 2 (8): 241–245.

12. Xu J., Xu F., Wang R. et al. Cigarette smoke-induced hypercapnic emphysema in C3H mice is associated with increases of macrophage metalloelastase and substance P in the lungs. Exp. Lung Res. 2007; 33 (5): 197–215.

13. Belvisi M.G., Bottomley K.M. The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs? Inflamm. Res. 2003; 52: 95–100.

14. Корытина Г.Ф., Ахмадишина Л.З., Янбаева Д.Г. и др. Ассоциация полиморфных вариантов генов ферментов матриксных металлопротеаз и антипротеаз с развитием и тяжестью течения хронической обструктивной болезни легких. Пульмонология 2008; 1: 33–38.

15. Atkinson J.J., Lutey B.A., Suzuki Y. et al. The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema. Am. J. Respir. Crit. Care Med. 2011; 183 (7): 876–884.